BioEdge 224 -- Tuesday, 24 October 2006

Home   |    Archives   |    Links   |    In the media
subscribe   |    subscribe my friend   |    to the editor   |    unsubscribe
BioEdge 224: Stem cell tumours: the threat is real

THIS WEEK


bullet 
Stem cell tumours: the threat is real
      Tumours appear in Parkinson's treatment
bullet 
Nonetheless, signs of progress
      Two steps forward for embryonic stem cells
bullet 
Suicide risk with cosmetic surgery
      Are customers stable psychologically?
bullet 
Methuselah mums OK, says university study
      Even in 50s, women can be good mothers
bullet 
Spending in Missouri cloning campaign shatters records
      Supporters of therapeutic cloning outspend by 14 to 1
bullet 
Dropping the word "cloning"
      Unexpected results from survey
bullet 
America's celebrity bioethicist, Arthur Caplan
      The ideas behind the sound grabs
bullet 
MIT's plug for embryonic stem cells
      Video supporting stem cell research
bullet 
Artificial sperm and eggs advancing slowly but surely
      More choice, more lesbian mothers
bullet 
UK man helps wife to die and walks free
      Decision welcomed by euthanasia lobby

STEM CELL TUMOURS: THE THREAT IS REAL

Although only this month renowned stem cell expert Alan Trounson, of Monash University in Melbourne, told the media that transplanted embryonic stem cells do not cause tumours in animal tests, he appears to be wrong. A fast-tracked on-line article in Nature Medicine by scientists at the University of Rochester Medical Centre in New York brings deeply disappointing news for supporters of embryonic stem cells and therapeutic cloning.

Steven Goldman and his colleagues experimented with rats which had a condition mimicking Parkinson's disease. When treated with mature neurons which had been created from human embryonic stem cells, they recovered all their lost motor function. So far, so good.

However, ten weeks after the transplant, the rats' brains were examined. To the dismay of the researchers, only about one-fifth of the transplanted cells were now producing dopamine (the chemical lacking in patients with Parkinson's). The rest had begun dividing uncontrollably into benign brain tumours.

Although a stem cell scientist quoted in the journal Science, Evan Snyder, of Burnham Institute of Medical Research, declared that further fine-tuning of the research will eventually find "the recipe to make it perfect", the language of the article was more pessimistic. "These promising results were unfortunately accompanied by several potentially disturbing outcomes," it said. First, the number of neurons producing dopamine fell sharply after one month, even though they had been "highly enriched" and differentiated cells. Second, "their persistent, uncontrolled and grossly homogeneous expansion over a 10-week span before the animals were killed nonetheless suggested graft-associated tumorigenesis". And it seemed clear, too, that the problem was not contamination by undifferentiated embryonic stem cells. The very cells which were supposed to cure caused the tumours.

The experiment provokes many questions, as the researchers do not know what would happen to the cells after 10 days. But they urge caution for therapeutic applications, "given the phenotypic instability and potential for undifferentiated donor cell expansion". ~ Nature Medicine, Oct 22; news@nature.com, Oct 22; Sydney Morning Herald, Oct 11   

NONETHELESS, SIGNS OF PROGRESS

Despite the discouraging news from New York this week, there have been some small advances towards clinical applications of embryonic stem cells. Novacell, a small San Diego biotech, has developed a process which turns human embryonic stem cells into pancreatic cells which could cure diabetes. The company says that it hopes to begin animal tests in 2008 and human clinical trials in 2009. According to the New York Times, however, "such timeline projections by companies often prove overly optimistic".

And at Johns Hopkins University in Baltimore, researchers have found that transplanting human embryonic stem cells into the spinal cords of rats bred to duplicate Lou Gehrig's disease delays the start of nerve damage and slightly prolongs their lives. Their study was published in the journal Transplantation. The lead researcher cautioned that clinical applications are still distant. ~ New York Times, Oct 20; Medical News Today, Oct 16   

SUICIDE RISK WITH COSMETIC SURGERY

Ethical storm clouds hover over cosmetic surgery at the best of times. Is it consistent with a doctor's ethic of healing to turn his skills into a consumer product? Is it right to use surgery to treat psychological problems? But the latest news on this front is even more disturbing. It suggests that one outcome of cosmetic surgery is not just changing your appearance, but ending your life. According to a special report in New Scientist, women with breast implants are two to three times as likely to kill themselves as those who have not. And this could be an underestimate, as these women also have a higher risk of road accidents, and some of these could be suicides.

What's going on? The first explanation is that nothing is. Dr James Wells, of Long Beach, California, told the magazine that most of the women who committed suicide all had their implants decades ago. "It's a very different world now," he says. "The implants are better, how we assess the patients is better, and implant failure rate is lower." However, epidemiologists are not convinced. A remote possibility is that leaks from the implants trigger changes in brain chemistry. Another is that women with breast implants are more likely to be substance abusers.

But the most plausible explanation is that the women who seek cosmetic surgery come with personality traits or psychiatric disorders which their doctors fail to detect. Indeed, a Danish study found that 8% of women with breast implants had earlier been in a psychiatric hospital. As well, an estimated 6% to 15% of patients who seek cosmetic surgery are believed to have a condition called body dysmorphic disorder, more commonly known as "imagined ugly syndrome". These people are obsessive about non-existent flaws in their personal appearance. They are 45 times as likely to commit suicide as normal people -- more than twice as much as people with major depression.

Dr Sabine Wilhelm, of Harvard Medical School, urges cosmetic surgeons to screen their patients for "psychological appropriateness". "Focus on their suffering and seek help from a psychologist," she says. And if they insist? "Cosmetic surgery is an elective procedure. Some surgeons say, 'If a patient elects to do it, shouldn't I go ahead?' My answer is: 'You as the surgeon can elect not to do it.'" ~ New Scientist, Oct 21   

METHUSELAH MUMS OK, SAYS UNIVERSITY STUDY

Britain's oldest mum, Dr Patricia Rashbrook, with her baby Are quality mothers younger or just more dedicated? Researchers from the University of Southern California say that age is no bar to being a perfectly good mother. After studying the mental and physical health of 150 women, of whom about 50 had become IVF mothers in their 50s, they found that there was no significant difference in the health or stress levels of the older women. "If we look from the perspective of stress and mental functioning, it doesn't seem we can restrict parenting based on these reasons," says lead researcher Anne Steiner.

A British specialist disputed the results. "The problem I have is not what happens to mothers at 50 to 55. What worries me is what happens when their children are 18 and they are in their 70s and 80s," said Bill Ledger, professor of obstetrics at the University of Sheffield. "I am not in favour of banning things, but I am concerned for the welfare of a child whose parents are as old as its peers grandparents."

The issue of geriatric mums is a lively one in the UK, where a 62- year-old doctor became Britain's oldest mother last year. The interim head of the country's fertility authority recently gave his support to older IVF mothers. Some in the IVF industry even frame it as a feminist issue, with one prominent specialist, Dr Gillian Lockwood, commenting: "I don't agree with the view that men may father a child into their 80s but it's wrong for women to want to extend their fertility after 45. That's ageist and sexist." At the moment more than 20 babies are born each year to women in their 50s in Britain. ~ Independent (UK), Oct 24; ThisIsLondon, Oct 22   

SPENDING IN MISSOURI CLONING CAMPAIGN SHATTERS RECORDS

Are backers of therapeutic cloning buying support in Missouri? An article in the St Louis Post-Dispatch has analysed the spending in a vigorous campaign for an amendment to the state constitution which would legalise cloning. Those in favour have outspent those against by 14 to 1 -­ US$28 million to $2 million.

Nearly all of the funds for the Coalition for Lifesaving Cures have come from a single philanthropic couple, Jim and Virginia Stowers, who have bankrolled the Stowers Institute, a first-class new medical research facility in St Louis. Support is broad for the initiative, claim supporters, even though the Stowers have given 97% of the funding so far. But opponents complain that it is not a broad-based citizen's initiative. "This isn't grass roots," says a political scientist at the University of Missouri at Columbia. "This is Astroturf."

By Missouri standards, the sums are staggering. The stem cell campaign is already more than twice as costly as any campaign for a Missouri ballot measure. The amount spent by supporters is greater than the total spent by all candidates combined in any race to date for any state office, including governor or Federal senator. "This isn't even close to David and Goliath," says a political scientist at Missouri State University. "I can't even come up with a good metaphor." ~ St Louis Post-Dispatch, Oct 17   

DROPPING THE WORD "CLONING"

The word "cloning" gives the public bad vibes, say biologists who support cloning of the therapeutic variety. They are trying to substitute the clumsier technical term "somatic cell nuclear transfer". The word "cloning" would be reserved for attempts to create a human baby and not a human embryo.

And the change works. Kathy Hudson, of the Genetics and Public Policy Center in Washington DC found that while only 29% of people surveyed approved of "cloning", 46% approved of "SCNT". But the change doesn't work altogether as expected. When people were asked whether they approved of creating babies with cloning, only 10% agreed. But when asked about creating babies with SCNT, the approval rating more than doubled, to 26%. ~ New Scientist, Oct 21   

AMERICA'S CELEBRITY BIOETHICIST, ARTHUR CAPLAN

Arthur Caplan (Technology Review, Chris Crisman) Let's say you're an American journalist whose editor has just tossed you a controversial medical story. Whom to ring? The first name in your rolodex will almost certainly be that of Arthur Caplan, chairman of the department of medical ethics at the University of Pennsylvania's School of Medicine. Because Caplan is quoted almost daily in the American press, he may be shaping the framework of ethical debates in the media more than anyone else.

So an interview with Caplan in the latest Technology Review, a magazine published at the Massachusetts Institute of Technology, helps to understand the forces shaping bioethical debates. "I'm a consequentialist," Caplan tells interviewer David Ewing Duncan. "I'm looking at outcomes. I'm trying to decide if a particular policy -- such as allowing surgeons to do face transplants -- would do more harm than good."

Fellow consequentialists include Princeton philosopher Peter Singer, but Caplan regards him as too rigorous in his logic. "He says that if animals are smarter than retarded children, then experiment on retarded children. I'm not willing to trust any theory that far. In general, I'm not looking for fundamental truths when I discuss ethics. What matters is what is most practical at a given time. I ask, 'What are the benefits and costs?' And I understand that the answer will change over time."

Caplan's bon mots are often insightful. When asked, for instance, why scientists look down on bioethicists, he responds: "In the culture of science, the only thing that counts is the science. If you're not doing that, it means you're not smart or good enough." These shrewd one-liners can seem facile, but this doesn't worry him: "It's a skill I have, and I'm a quick study, and I can track a lot of stuff." ~ Technology Review, Sept-Oct 2006   

MIT'S PLUG FOR EMBRYONIC STEM CELLS

While we're still at MIT and Technology Review, take a look at a video on embryonic stem cell research on the magazine's website featuring an MIT professor who is one of the leading figures in the field, Rudolph Jaenisch.

This persuasive production gives the impression that all scientists are in favour of embryonic stem cell research -- and presumably therapeutic cloning -- although the word cloning is, significantly, never mentioned. There were no interviews with another stem cell specialist at MIT who strongly opposes destructive embryo research and who insists that it will never work, James Sherley. ~ Technology Review, Sept-Oct 2006   

ARTIFICIAL SPERM AND EGGS ADVANCING SLOWLY BUT SURELY

A special feature in this week's New Scientist reviews progress towards the creation of eggs and sperm from embryonic stem cells. In the short term, it's unlikely, despite headline-grabbing stories about the birth of mice from artificial sperm. But in the long term, it's clearly possible, especially as many groups around the world are working on producing fertile eggs and sperm.

The social implications could be immense, especially for infertile couples. Artificially produced eggs would mean more choice, says the New Scientist. "A limitless supply of eggs could be used to produce hundreds of embryos for any one couple, making it feasible for would-be parents to use genetic screening to choose several desirable traits as well as ensuring embryos are free from disease- causing mutations." It would also be possible for gay and lesbian couples to have their own genetically related children (although lesbians could not have boys.)

Progress is slow. So far, few artificial eggs have developed far after fertilisation. "Oocytes are very sensitive cells and it doesn't take much to send them off the rails," says Alan Trounson, of Monash University. "Getting them to mature and undergo meiosis is a big hurdle." Mice have been born from artificial sperm, but these were poor swimmers and had to be injected into the eggs. All of the resulting mice died within five months and all of them had serious health problems.

As with IVF, the problem seems to be imprinting. In vitro, the imprinting process is disrupted, leading to the death of the embryo or serious abnormalities. However, says the magazine, "many in the field now think it is only a matter of time before the first child conceived with a lab-grown sperm or egg is born." ~ New Scientist, Oct 20   

UK MAN HELPS WIFE TO DIE AND WALKS FREE

A husband has walked free from a British court after helping his seriously disabled wife to commit suicide. He was given a nine-month suspended jail sentence. A "devoted husband", David March found one day last year that his wife had taken Valium and had placed a plastic bag over her head. She was suffering from multiple sclerosis. He tightened the string around the bag and she died half an hour later.

Predictably, the decision was controversial. The UK's euthanasia lobby, Dignity in Dying, welcomed it, but a spokesman for the British Council for Disabled People asked: "what kind of message is this sending out to society where it is perceived to be easier to kill a disabled person rather than support them to live with dignity?" ~ London Telegraph, Oct 21   

 

  

How to support BioEdge
BioEdge and ABI's other services rely completely upon the generosity of private benefactors and volunteer workers. ABI has no institutional backing. If you would like to support the best bioethics news service on the Web, you can do it painlessly through Paymate, a thoroughly reliable payment service which is affiliated with the internet auction site eBay.

Just access the Paymate website and follow the instructions. You will need to fill in our email address, which is bioedge@australasianbioethics.org. You will also have to give your credit card details and an amount in Australian or US dollars. Thanks!

  

 

To subscribe to our weekly email newsletter,
click here for the HTML version.
click here for the text version.
To cancel your newsletter subscription, click here.

Australasian Bioethics Information
ISSN 1446-2117
Website:www.australasianbioethics.org
BioEdge editor: Michael Cook
New Zealand Contributing Editor: Carolyn Moynihan


The BioEdge privacy policy
Your subscription information will be kept private and is not publicly accessible.
Your email address and other information will never be sold to a third party or given out
without your consent. You may cancel your subscription at any time.